CompletedNCT01214135

A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

Observational studyAges 18–65Sweden

The study in practice

Understand this study

Listed age limits: 18 years to 65 years.

Listed locations: Falköping and 13 more locationsSee all locations and recruitment

Study clarity

Study start dateOctober 2010

Recruitment status: Completed
Enrollment listed in the registry: 300
Sponsor: AstraZeneca
Sponsor type: Unknown or unclear
Study type: Observational
Intervention type: Interview / survey / observational
Study phase: Not clearly listed
Locations: Sweden
Age range: From 18 Years to 65 Years
Official registry ID: NCT01214135
Official title: Show the full official title
A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Inpatients With Schizophrenia

Completed

Falköping · Gothenburg · Helsingborg

11 more locations

FAQ

Who is behind this study?

The study sponsor is AstraZeneca.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.